MARKET

ATHE

ATHE

Alterity Therapeutics Ltd
NASDAQ
3.430
-0.054
-1.55%
Closed 18:32 12/04 EST
OPEN
3.445
PREV CLOSE
3.484
HIGH
3.465
LOW
3.310
VOLUME
5.60K
TURNOVER
0
52 WEEK HIGH
7.00
52 WEEK LOW
1.410
MARKET CAP
62.17M
P/E (TTM)
-4.5813
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ATHE last week (1124-1128)?
Weekly Report · 4d ago
Alterity Therapeutics Appoints Julian Babarczy as Director
Reuters · 11/24 16:19
Weekly Report: what happened at ATHE last week (1117-1121)?
Weekly Report · 11/24 09:05
Alterity Therapeutics Held Annual General Meeting
Reuters · 11/21 11:35
Alterity Therapeutics Announces Board Reshuffle as Chairman and Director Retire
Reuters · 11/21 11:14
Alterity ‘never lost sight’ of interest in Parkinson’s disease, CEO says
TipRanks · 11/20 19:05
Alterity CEO says to meet with FDA, move forward with Phase 3 study
TipRanks · 11/20 19:05
Alterity ‘really emerging’ as U.S. company, CEO tells The Fly
TipRanks · 11/20 19:05
More
About ATHE
Alterity Therapeutics Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing disease modifying treatments for neurodegenerative diseases. The Company's lead asset, ATH434, is to treat various Parkinsonian disorders. ATH434 is an oral agent designed to inhibit the aggregation of pathological proteins implicated in neurodegeneration. It has the potential to treat Parkinson's disease, as well as various Parkinsonian disorders, such as Multiple System Atrophy (MSA). The Company also has a drug discovery platform generating patentable chemical compounds to intercede in disease processes. ATH434 has been granted Orphan designation for the treatment of MSA. The Phase II clinical trial is a randomized, double-blind, placebo-controlled investigation of ATH434 in patients with early-stage MSA.

Webull offers Alterity Therapeutics Ltd (ADR) stock information, including NASDAQ: ATHE real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATHE stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATHE stock methods without spending real money on the virtual paper trading platform.